Bruker Announces Acquisition of MERLIN to Add Selected Antibiotic Resistance and Susceptibility Testing to its MALDI Biotyper® Microbial Identification Platform

Tuesday, September 26, 2017 General News
Email Print This Page Comment bookmark
Font : A-A+

MERLIN will become Bruker´s Center of Excellence for specialty biochemical and selected, high-value MALDI Biotyper-based antibiotic resistance and susceptibility testing



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Find a Doctor
Advertisement

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook